Berenberg Downgrades Fresenius Medical Care (FMS) to Hold
Berenberg analyst Harry Gillis downgraded Fresenius Medical Care (NYSE: FMS) from Buy to Hold with a price target of $24.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

